{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:40:06Z","timestamp":1778784006628,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.idc.2018.04.008","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T06:19:54Z","timestamp":1535005194000},"page":"581-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"32","author":[{"given":"Christine E.","family":"Koval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2018.04.008_bib1","series-title":"Human cytomegalovirus: 325. Current topics in microbiology and immunology","article-title":"Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease","author":"Britt","year":"2008"},{"key":"10.1016\/j.idc.2018.04.008_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/infdis\/171.4.1002","article-title":"Detection of cytomegalovirus, DNA, RNA and antibody in normal blood donor blood","volume":"171","author":"Zhang","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/139.6.728","article-title":"Summary of a workshop on cytomegalovirus infections in organ transplantation","volume":"139","author":"Rubin","year":"1979","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2018.04.008_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib6","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.4049\/jimmunol.151.9.4455","article-title":"Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains","volume":"151","author":"Beersma","year":"1993","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.idc.2018.04.008_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4 and CD8 T\u00a0cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.idc.2018.04.008_bib8","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","article-title":"Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection","volume":"89","author":"Gerna","year":"2008","journal-title":"J\u00a0Gen Virol"},{"issue":"3","key":"10.1016\/j.idc.2018.04.008_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fvl.12.8","article-title":"The immune response to human CMV","volume":"7","author":"LaRosa","year":"2012","journal-title":"Future Virol"},{"key":"10.1016\/j.idc.2018.04.008_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/01.TP.0000083894.61333.56","article-title":"Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity","volume":"76","author":"Sester","year":"2003","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.idc.2018.04.008_bib11","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2011.03674.x","article-title":"Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials","volume":"11","author":"Brennan","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1399-3062.2009.00448.x","article-title":"Lower incidence of cytomegalovirus with everolimus versus mycophoenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study","volume":"12","author":"Vigano","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trre.2016.04.001","article-title":"Management of cytomegalovirus infection in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations","volume":"30","author":"Torre-Cisneros","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"issue":"2","key":"10.1016\/j.idc.2018.04.008_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.idc.2013.02.012","article-title":"Infections in intestinal and multivisceral transplant recipients","volume":"27","author":"Timpone","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2018.04.008_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tid.12507","article-title":"Resistant cytomegalovirus in intestinal and multivisceral transplant recipients","volume":"18","author":"Timpone","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1399-3046.2011.01628.x","article-title":"Incidence, risk factors, and outcomes associated with cytomegalovirus disease in small bowel transplant recipients","volume":"16","author":"Florescu","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib17","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1128\/JVI.67.9.5360-5366.1993","article-title":"Lungs are a major organ site of cytomegalovirus latency and recurrence","volume":"67","author":"Balthesen","year":"1993","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.idc.2018.04.008_bib18","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","article-title":"The indirect effects of cytomegalovirus infection on the outcome of organ transplantation","volume":"261","author":"Rubin","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2018.04.008_bib19","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid organ transplants: a systematic review of randomized controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.04.008_bib20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R- kidney transplant recipients is associated with long term reduction in cytomegalovirus disease: two year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.04.008_bib21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/rccm.200310-1405OC","article-title":"Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome","volume":"170","author":"Tamm","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2018.04.008_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.04.008_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/TP.0000000000000832","article-title":"Cytomegalovirus infection after intestinal\/multivisceral transplantation: a single-center experience with 210 cases","volume":"100","author":"Nagai","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.04.008_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of cytomegalovirus load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.04.008_bib25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/lt.23460","article-title":"Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients","volume":"18","author":"Bodro","year":"2012","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.idc.2018.04.008_bib26","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","author":"Hodson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2018.04.008_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","article-title":"Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation; a randomized controlled trial","volume":"152","author":"Palmer","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2018.04.008_bib28","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.healun.2011.02.017","article-title":"Long-term efficacy and safety of 12\u00a0months of valganciclovir prophylaxis compared with 3\u00a0months after lung transplantation: a single-center, long-term follow-up analysis from a randomized controlled cytomegalovirus prevention trial","volume":"30","author":"Finlen Copeland","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.idc.2018.04.008_bib31","article-title":"Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients","author":"Owers","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2018.04.008_bib32","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajt.12006","article-title":"CMV: prevention, diagnosis and therapy","volume":"13","author":"Kotton","year":"2013","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.idc.2018.04.008_bib34","first-page":"1205","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"2009","author":"Asberg","year":"2006","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.idc.2018.04.008_bib35","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/TP.0000000000001418","article-title":"Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection","volume":"100","author":"Avery","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.idc.2018.04.008_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/sur.2015.266","article-title":"Use of cidofovir for cytomegalovirus disease refractory to ganciclovir in solid organ recipients","volume":"18","author":"Bonatti","year":"2017","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.idc.2018.04.008_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4560745","article-title":"Treatment of cytomegalovirus infection with cidofovir and CMV immune globulin in a lung transplant recipient","author":"Wilkens","year":"2016","journal-title":"Case Rep Transplant"},{"issue":"20","key":"10.1016\/j.idc.2018.04.008_bib38","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The novel anticytomegalovirus compound AIC246 (letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase","volume":"85","author":"Goldner","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"3","key":"10.1016\/j.idc.2018.04.008_bib39","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In\u00a0vitro and in\u00a0vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"25","key":"10.1016\/j.idc.2018.04.008_bib40","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.idc.2018.04.008_bib41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2018.04.008_bib42","unstructured":"US FDA. PREVYMISTM (letermovir) tablet and injection: NDA approval letter. 2017. Available at: https:\/\/www.fda.gov. Accessed March 15, 2018."},{"issue":"1","key":"10.1016\/j.idc.2018.04.008_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of cytomegalovirus infection in kidney transplant recipients with letermovir; results of a phase 2a study","volume":"27","author":"Stoelben","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.idc.2018.04.008_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2011.03530.x","article-title":"First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246","volume":"11","author":"Kaul","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.idc.2018.04.008_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cpdd.388","article-title":"Pharmacokinetics and safety of letermovir coadministered with cyclosporine A or tacrolimus in healthy subjects","volume":"7","author":"Kropeit","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.idc.2018.04.008_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0012.2007.00750.x","article-title":"CMV hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis","volume":"22","author":"Bonaros","year":"2008","journal-title":"Clin Transpl"},{"issue":"3S","key":"10.1016\/j.idc.2018.04.008_bib47","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/TP.0000000000001096","article-title":"Cytomegalovirus hyper immunoglobulin for CMV prophylaxis in thoracic transplantation","volume":"100","author":"Rea","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.idc.2018.04.008_bib48","first-page":"187","article-title":"Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir","volume":"4","author":"Verdonck","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-109-10-777","article-title":"Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high dose intravenous immune globulin","volume":"15","author":"Emanuel","year":"1988","journal-title":"Ann Int Med"},{"key":"10.1016\/j.idc.2018.04.008_bib50","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.healun.2004.11.016","article-title":"The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study","volume":"24","author":"Yamani","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.idc.2018.04.008_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000381470","article-title":"Use of leflunomide in renal transplant recipients with ganciclovir-resistant\/refractory cytomegalovirus infection: a case series from the university of Chicago","volume":"5","author":"Chon","year":"2015","journal-title":"Case Rep Nephrol Dial"},{"issue":"1","key":"10.1016\/j.idc.2018.04.008_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-3062.2006.00170.x","article-title":"Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation","volume":"9","author":"Battiwalla","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2018.04.008_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cid\/ciq050","article-title":"Artesunate is ineffective in controlling valganciclovir-resistant cytomegalovirus infection","volume":"52","author":"Lau","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib55","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State of the art monitoring of cytomegalovirus-specific immunity for the prediction of cytomegalovirus disease after organ transplant: a primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.04.008_bib56","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.idc.2018.04.008_bib57","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T\u00a0cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.idc.2018.04.008_bib58","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.140123497","article-title":"Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy","volume":"97","author":"Emery","year":"2000","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.idc.2018.04.008_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2017.03.014","article-title":"Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance","volume":"90","author":"Lopez-Aladid","year":"2017","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.idc.2018.04.008_bib60","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/TP.0b013e31828555ac","article-title":"Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance inducing mutations","volume":"95","author":"Gracia-Ahufinger","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.04.008_bib61","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/340101","article-title":"Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients","volume":"34","author":"Mylonakis","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2018.04.008_bib62","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/cid\/cis1035","article-title":"Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients","volume":"56","author":"LePage","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.04.008_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.04.008_bib64","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2018.04.008_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.csbj.2015.01.003","article-title":"Antiviral drug and multidrug resistance in cytomegalovirus infected SCT patients","volume":"13","author":"Gohring","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.idc.2018.04.008_bib66","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e32834cfb58","article-title":"The biology of cytomegalovirus drug resistance","volume":"24","author":"Hakki","year":"2011","journal-title":"Curr Opin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:08:18Z","timestamp":1720534098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552018300436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0891552018300436"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2018.04.008","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and Treatment of Cytomegalovirus Infections in Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2018.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}